Biltmore Family Office’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Biltmore Family Office's IBB Position: Q1 2026 in Review
Biltmore Family Office held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 8,704 shares worth $1.47M. The position accounts for 0.21% of the portfolio, ranked #79.
Biltmore Family Office first reported a position in IBB in Q2 2019 and has held it in 28 quarters since. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Biltmore Family Office held 8,704 shares of iShares Biotechnology ETF worth $1.47M as of Q1 2026.
- Biltmore Family Office left its iShares Biotechnology ETF share count unchanged in Q1 2026.
- iShares Biotechnology ETF made up 0.21% of Biltmore Family Office's portfolio in Q1 2026, its #79 holding.
- Biltmore Family Office first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 28 quarters since.
- 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Biltmore Family Office's 13F filing for Q1 2026, filed 11 May 2026.